{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T20:01:04Z","timestamp":1648843264279},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1097\/01.hjh.0000170394.99697.b3","type":"journal-article","created":{"date-parts":[[2005,5,13]],"date-time":"2005-05-13T08:01:36Z","timestamp":1115971296000},"page":"1273-1275","source":"Crossref","is-referenced-by-count":4,"title":["Bartter's and Gitelman's syndromes: a confirm in humans of the utility of Rho kinase inhibition for cardiovascular protection"],"prefix":"10.1097","volume":"23","author":[{"given":"Lorenzo A","family":"Cal\u00f2","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisa","family":"Pagnin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelangelo","family":"Sartori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Semplicini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Achille C","family":"Pessina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-26-20210208","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/361315a0","article-title":"Inositol trisphosphate and calcium signalling","volume":"361","author":"Berridge","year":"1993","journal-title":"Nature"},{"key":"R2-26-20210208","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1152\/physrev.00023.2003","article-title":"Ca2+ sensitivity of smooth muscle and nonmuscle myosin II: modulated by G-proteins, kinases, and myosin phosphatase","volume":"83","author":"Somlyo","year":"2003","journal-title":"Physiol Rev"},{"key":"R3-26-20210208","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11906-003-0013-1","article-title":"The role of RhoA and Rho-associated kinase in vascular smooth muscle contraction","volume":"5","author":"Sward","year":"2003","journal-title":"Curr Hypertens Rep"},{"key":"R4-26-20210208","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1161\/hy1201.096541","article-title":"Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans","volume":"38","author":"Masumoto","year":"2001","journal-title":"Hypertension"},{"key":"R5-26-20210208","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11906-001-0028-4","article-title":"RhoA\/Rho-kinase, vascular changes and hypertension","volume":"3","author":"Chitaley","year":"2001","journal-title":"Curr Hypertens Rep"},{"key":"R6-26-20210208","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1161\/01.RES.0000096650.91688.28","article-title":"Long-term inhibition of Rho-Kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo. Effect on endothelial NAD(P)H oxidase system","volume":"93","author":"Higashi","year":"2003","journal-title":"Circ Res"},{"key":"R7-26-20210208","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/01.HYP.35.1.313","article-title":"Involvement of Rho-kinase in angiotensin II-induced hypertrophy of rat vascular smooth muscle cells","volume":"35","author":"Yamakawa","year":"2000","journal-title":"Hypertension"},{"key":"R8-26-20210208","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1161\/hy0202.103271","article-title":"Important role of Rho-kinase in the pathogenesis of cardiovascular inflammation and remodeling induced by long-term blockade of nitric oxide synthesis in rats","volume":"39","author":"Kataoka","year":"2002","journal-title":"Hypertension"},{"key":"R9-26-20210208","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/01.ATV.21.5.868","article-title":"Critical role of Rho-kinase and MEK-ERK pathways for angiotensin II-induced plasminogen activator inhibitor type-1 gene expression","volume":"21","author":"Takeda","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R10-26-20210208","first-page":"H1744","article-title":"Gene transfer of dominant negative Rho kinase suppresses neointimal formation after balloon injury in pigs","volume":"278","author":"Eto","year":"2000","journal-title":"Am J Physiol"},{"key":"R11-26-20210208","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1161\/01.ATV.0000142813.33538.82","article-title":"Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3 kinase\/protein kinase Akt and cardiovascular protection","volume":"24","author":"Wolfrum","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R12-26-20210208","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00004872-200501000-00017","article-title":"Cardioprotective mechanisms of Rho-kinase inhibition associated with eNOS and oxidative stress-LOX-1 pathway in Dahl salt-sensitive hypertensive rats","volume":"23","author":"Mita","year":"2005","journal-title":"J Hypertens"},{"key":"R13-26-20210208","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/10408360091174295","article-title":"Control of vascular tone in the syndromes of Bartter and Gitelman","volume":"37","author":"Cal\u00f2","year":"2000","journal-title":"Crit Rev Clin Lab Sci"},{"key":"R14-26-20210208","doi-asserted-by":"crossref","first-page":"393","DOI":"10.5414\/CNP59393","article-title":"Bartter's\/Gitelman's syndrome: a model for the relationships between hypertension, angiotensin II, oxidative stress and remodeling","volume":"59","author":"Cal\u00f2","year":"2003","journal-title":"Clin Nephrol"},{"key":"R15-26-20210208","doi-asserted-by":"crossref","first-page":"4153","DOI":"10.1210\/jc.2004-0498","article-title":"Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's\/Gitelman's sydrome. A role in the control of vascular tone and implication for hypertension","volume":"89","author":"Cal\u00f2","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R16-26-20210208","first-page":"882","article-title":"Abnormalities of Gq-mediated cell signaling in Bartter and Gitelman syndromes","volume":"60","author":"Calo","year":"2001","journal-title":"Kidney Int"},{"key":"R17-26-20210208","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1523-1755.2002.00128.x","article-title":"Reduced content of alpha subunit of Gq protein in monocytes of Bartter and Gitelman syndromes: relationship with vascular hyporeactivity","volume":"61","author":"Cal\u00f2","year":"2002","journal-title":"Kidney Int"},{"key":"R18-26-20210208","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1159\/000188941","article-title":"Intracellular calcium signalling and vascular reactivity in Bartter's syndrome","volume":"72","author":"Calo","year":"1996","journal-title":"Nephron"},{"key":"R19-26-20210208","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1042\/cs0720483","article-title":"Resting and stimulated cytosolic free calcium levels in neutrophils from patients with Bartter's syndrome","volume":"72","author":"Di Virgilio","year":"1987","journal-title":"Clin Sci"},{"key":"R20-26-20210208","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1093\/ndt\/gfg204","article-title":"Oxidative stress-related factors in Bartter's and Gitelman's syndromes: relevance for angiotensin II signalling","volume":"18","author":"Cal\u00f2","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R21-26-20210208","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1097\/00004872-199816070-00014","article-title":"Reduced susceptibility of low density lipoprotein to oxidation in patients with overproduction of nitric oxide (Bartter's and Gitelman's syndrome)","volume":"16","author":"Calo","year":"1998","journal-title":"J Hypertens"},{"key":"R22-26-20210208","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1097\/00004872-200410000-00019","article-title":"Rho kinase and PAI-1 in Bartter's\/Gitelman's syndromes: relationship to angiotensin II signaling","volume":"22","author":"Pagnin","year":"2004","journal-title":"J Hypertens"},{"key":"R23-26-20210208","first-page":"12","article-title":"Increased endothelial nitric oxide synthase mRNA level in Bartter's and Gitelman's syndrome. Relationship to vascular reactivity","volume":"51","author":"Cal\u00f2","year":"1999","journal-title":"Clin Nephrol"},{"key":"R24-26-20210208","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0272-6386(96)90514-4","article-title":"Increased urinary NO2 \u2212\/NO3 \u2212 and cyclic GMP levels in patients with Bartter's syndrome: relationship to vascular reactivity","volume":"27","author":"Cal\u00f2","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"R25-26-20210208","doi-asserted-by":"crossref","first-page":"8919","DOI":"10.1074\/jbc.M309660200","article-title":"Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase\/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol","volume":"279","author":"Martin","year":"2004","journal-title":"J Biol Chem"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.hjh.0000170394.99697.b3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T20:48:16Z","timestamp":1620938896000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004872-200506000-00026"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.1097\/01.hjh.0000170394.99697.b3","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}